← Evidence map

ArticleCell death & disease2025

CUL4B promotes hepatocellular carcinoma progression and oxaliplatin resistance by facilitating FUS degradation.

Jun-Dong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41392287